CAR-T Therapy Beyond B-Cell Hematological Malignancies

Despite the advances of CAR-T cells in certain hematological malignancies, mostly from B-cell derivations such as non-Hodgkin lymphomas, acute lymphoblastic leukemia and multiple myeloma, a significant portion of other hematological and non-hematological pathologies can benefit from this innovative...

Full description

Saved in:
Bibliographic Details
Main Authors: Martina Canichella, Paolo de Fabritiis
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/1/41
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items